Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjersti Flatmark

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Acta Oncologica (Stockholm, Sweden)|December 17, 2021
MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohortsFranziska Knuth, Ingvild Askim Adde, Bao Ngoc Huynh, et al.
British Journal of Cancer|February 23, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancerAnne Hansen Ree, Paula A Bousquet, Tina Visnovska, et al.
Oncoimmunology|July 2, 2024
Complete response of metastatic microsatellite-stable <i>BRAF</i> V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockadeAnne Hansen Ree, Eirik Høye, Ying Esbensen, et al.
Translational Oncology|May 17, 2019
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node MetastasesVivi Ann Flørenes, Karine Flem-Karlsen, Erin McFadden, et al.
Annals of Surgery|June 29, 2017
Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled TrialÅsmund Avdem Fretland, Vegar Johansen Dagenborg, Gudrun Maria Waaler Bjørnelv, et al.
JCO Precision Oncology|April 27, 2022
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case SeriesMargherita Ambrosini, Marzia Del Re, Paolo Manca, et al.
Clinical and Translational Radiation Oncology|December 25, 2019
Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?Sebastian Meltzer, Kine Mari Bakke, Karina Lund Rød, et al.
Cell Reports. Medicine|September 9, 2025
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumorsRafaela Abrantes, Christopher Forcados, David J Warren, et al.
Acta Oncologica (Stockholm, Sweden)|March 27, 2020
Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction studyAnne Hansen Ree, Vigdis Nygaard, Kjetil Boye, et al.
ESMO Open|August 2, 2017
Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimateAnne Hansen Ree, Hege G Russnes, Daniel Heinrich, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Acta Oncologica (Stockholm, Sweden)|December 17, 2021
MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohortsFranziska Knuth, Ingvild Askim Adde, Bao Ngoc Huynh, et al.
British Journal of Cancer|February 23, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancerAnne Hansen Ree, Paula A Bousquet, Tina Visnovska, et al.
Oncoimmunology|July 2, 2024
Complete response of metastatic microsatellite-stable <i>BRAF</i> V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockadeAnne Hansen Ree, Eirik Høye, Ying Esbensen, et al.
Translational Oncology|May 17, 2019
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node MetastasesVivi Ann Flørenes, Karine Flem-Karlsen, Erin McFadden, et al.
Annals of Surgery|June 29, 2017
Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled TrialÅsmund Avdem Fretland, Vegar Johansen Dagenborg, Gudrun Maria Waaler Bjørnelv, et al.
JCO Precision Oncology|April 27, 2022
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case SeriesMargherita Ambrosini, Marzia Del Re, Paolo Manca, et al.
Clinical and Translational Radiation Oncology|December 25, 2019
Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?Sebastian Meltzer, Kine Mari Bakke, Karina Lund Rød, et al.
Cell Reports. Medicine|September 9, 2025
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumorsRafaela Abrantes, Christopher Forcados, David J Warren, et al.
Acta Oncologica (Stockholm, Sweden)|March 27, 2020
Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction studyAnne Hansen Ree, Vigdis Nygaard, Kjetil Boye, et al.
ESMO Open|August 2, 2017
Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimateAnne Hansen Ree, Hege G Russnes, Daniel Heinrich, et al.
Pageof 14